This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mitchell, J. M. et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat. Med. https://doi.org/10.1038/s41591-021-01336-3 (2021).
American Psychological Association. Clinical practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults 1st edn (APA, 2017).
National Institute for Health and Care Excellence. Post-traumatic Stress Disorder. NIC Guideline [NG116] (National Institute for Health and Care Excellence, 2018).
Lee, D. J. et al. Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: Systemic review and meta- analyses to determine first-line treatments. Depress. Anxiety 33, 792–806 (2016).
Mavranezouli, I. et al. Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol. Med. 50, 542–555 (2020). 130.
Karatzias, T. et al. Psychological interventions for ICD-11 complex PTSD symptoms: systematic review and meta-analysis. Psychol. Med. 49, 1761–1775 (2019). 133.
Ehlers, A. et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am. J. Psychiatry 171, 294–304 (2014).
Springer, K. S., Levy, H. C. & Tolin, D. F. Remission in CBT for adult anxiety disorders: a meta analysis. Clin. Psychol. Rev. 61, 1–8 (2018).
Resick, P. A., Williams, L. F., Suvak, M. K., Monson, C. M. & Gradus, J. L. Long-term outcomes of cognitive-behavioral treatments for posttraumatic stress disorder among female rape survivors. J. Consulting Clin. Psychol. 80, 201–210 (2012).
Schenk, S. & Newcombe, D. Methylenedioxymethamphetamine (MDMA) in psychiatry: pros, cons, and suggestions. J. Clin. Psychopharmacol. 38, 632–638 (2018).
Author information
Authors and Affiliations
Contributions
J. Ø. H. and I. A. C. conceptualized the main arguments, and J. Ø. H. wrote the first draft. J. Ø. H., F. N. and I. A. C. contributed substantially to the revisions of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Halvorsen, J.Ø., Naudet, F. & Cristea, I.A. Challenges with benchmarking of MDMA-assisted psychotherapy. Nat Med 27, 1689–1690 (2021). https://doi.org/10.1038/s41591-021-01525-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-021-01525-0
This article is cited by
-
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
European Child & Adolescent Psychiatry (2023)